Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tilray Brands, Inc. - Common Stock (NQ: TLRY )

0.4437 +0.0034 (+0.77%)
Streaming Delayed Price Updated: 11:52 AM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Tilray Brands, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
93 94 Next >
Bearish Sentiment Across The Cannabis Space - Check Full Movers For April 23, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
What's Going On With Tilray Brands Stock Today?
Tilray launches new whiskey. Recently it planned a reverse split to meet Nasdaq listing standards. 
Via Benzinga
Philip Morris (PM) To Report Earnings Tomorrow: Here Is What To Expect
Tobacco company Philip Morris International (NYSE:PM) will be reporting earnings tomorrow before market open. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
The Canadian Cannabis Report- Mondaty April 21
The past, present, and future of the Canadian cannabis sector. 
Via Talk Markets
Topics Cannabis ETFs Stocks / Equities
Exposures Cannabis
Tilray Brands Earnings Preview
Via Benzinga
Marijuana Stock Movers For April 18, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
This Week In Cannabis: Carmelo's NY Launch, Federal Reform, Cancer Study, Avicanna's Growth, Tilray's Split, DeSantis Fallout, Slovenia's Big Move And More
Cannabis news this week: Congress revives cannabis reform, Slovenia leads Europe, Tyson takes charge and science backs cannabis for cancer care. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For April 17, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray Stock Hit A New 52-Week Low Today: What's Going On?
Tilray shares are trading lower by 6.2% during Thursday's session. The company on Thursday announced plans to implement a reverse stock split. 
Via Benzinga
Why Cannabis Co. Tilray (TLRY) Is Trading Down Today
Tilray shares fall 6.8% after announcing a proposed reverse stock split ahead of a June 10 shareholder vote. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Vegan, Sugar-Free, And Now In Australia: Tilray's Edibles Aren't Your Average Medical Launch
Tilray Brands Inc. (NASDAQ: TLRY) has launched its first medical cannabis edibles in Australia through Tilray Medical. The new sugar-free, vegan Good Supply Pastilles offer THC and CBD options,... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
3 Crashing Stocks I Wouldn't Buy Right Now
Via The Motley Fool
Topics Artificial Intelligence Electric Vehicles Government
Exposures Artificial Intelligence Electric Vehicles Political
1 Underrated Growth Industry That Could Be Well Protected Against Tariffs
Via The Motley Fool
Topics Cannabis Economy Law Enforcement
Exposures Cannabis Economy Legal
The Canasian Cannabis Report- Monday, April 14
The past, present and futur eof the Canasian cannabis sector. 
Via Talk Markets
Topics Cannabis ETFs Stocks / Equities
Exposures Cannabis
How I Turned $5,000 Into $20,000 - Real Capital Allocation Strategy
Via Talk Markets
Topics ETFs Stocks / Equities
Cannabis Stock Gainers And Losers From April 11, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Week In Cannabis: Delays, Decrees And Deals Reshape The Global Playbook
Cannabis news of the week: Germany holds CanG, US delays, Chile bill; Italy hemp ban; SNDL expands, Tilray cuts outlook, US sales forecast –$21 B. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From April 10, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Sentiment Across The Cannabis Space - Check Full Movers For April 9, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report- Monday, April 7
The past, present, and future of the Canadian cannabis sector. 
Via Talk Markets
Topics Cannabis ETFs Stocks / Equities
Exposures Cannabis
Why Tilray (TLRY) Stock Is Trading Lower Today
Shares of cannabis company Tilray Brands (NASDAQ:TLRY) fell 19.7% in the afternoon session after the company reported weak fiscal third-quarter 2025 results that missed analysts' sales and EBITDA... 
Via StockStory
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From April 8, 2025
Via Benzinga
Topics Cannabis
Exposures Cannabis
3 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Crude Oil Gains 1%; Walgreens Posts Upbeat Earnings
Via Benzinga
Exposures Fossil Fuels
Tilray Brands Reports Lower Cannabis Sales In Q3, Trims 2025 Revenue Outlook
Tilray Brands missed Q3 revenue expectations and lowered FY25 outlook, while beverage and wellness units posted year-over-year revenue increases. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Constellation Brands Earnings: What To Look For From STZ
Beer, wine, and spirits company Constellation Brands (NYSE:STZ) will be reporting results tomorrow after market close. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tilray (NASDAQ:TLRY) Misses Q1 Revenue Estimates
Cannabis company Tilray Brands (NASDAQ:TLRY) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 1.4% year on year to $185.8 million. The company’s full-year revenue... 
Via StockStory
Topics Cannabis
Exposures Cannabis
2 Beaten-Down Stocks That Still Aren't Worth Buying
Via The Motley Fool
Topics Cannabis Government Law Enforcement
Exposures Cannabis Legal Political
Earnings Scheduled For April 8, 2025
Via Benzinga
Tilray (TLRY) Reports Q1: Everything You Need To Know Ahead Of Earnings
Cannabis company Tilray Brands (NASDAQ:TLRY) will be reporting results tomorrow before the bell. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence Cannabis
Exposures Artificial Intelligence Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
93 94 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.